Effects of dose and sex on the pharmacokinetics of piroxicam in the rat

Biopharm Drug Dispos. 1990 Apr;11(3):215-25. doi: 10.1002/bdd.2510110306.


The effects of dose and sex on the pharmacokinetics of piroxicam were studied in the rat. Piroxicam was administered intravenously at doses of 0.50 and 5.0 mg kg-1 to male and female rats. Plasma drug concentrations were determined by a highly sensitive high-performance liquid chromatographic technique. Non-compartmental pharmacokinetic parameters were calculated by area/moment analysis. A prolonged terminal half-life averaging 13.3 h in male rats and 40.8 h in female rats was observed. Dose had no effect on the disposition of piroxicam. The sex of the rat, however, had a marked effect on piroxicam pharmacokinetics, with mean total clearance differing three-fold from 0.0184 l h-1 kg-1 in male rats to 0.00622 l h-1 kg-1 in female rats. The free fraction of piroxicam in serum was greater in male rats than in female rats owing to a higher association constant for piroxicam binding to female rat serum proteins. Free piroxicam clearance differed approximately two-fold with mean values of 0.764 l h-1 kg-1 and 0.418 l h-1 kg-1 in male and female rats, respectively. Thus, protein binding partially explained the sex-dependent disposition of piroxicam. However, sex-dependent metabolism of the drug also appears to be a major determinant of sex-related differences in piroxicam pharmacokinetics. Steady-state volume of distribution was unaffected by sex. Half-life and mean residence time were three-fold greater in female rats owing to the three-fold lower clearance value compared to male rats.

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Female
  • Injections, Intravenous
  • Male
  • Piroxicam / administration & dosage
  • Piroxicam / blood
  • Piroxicam / pharmacokinetics*
  • Protein Binding
  • Rats
  • Rats, Inbred Strains
  • Sex Factors


  • Piroxicam